A detailed history of E. Ohman J:Or Asset Management Ab transactions in Repligen Corp stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 33,689 shares of RGEN stock, worth $5.13 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
33,689
Holding current value
$5.13 Million
% of portfolio
0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 12, 2026

BUY
$142.82 - $166.33 $4.81 Million - $5.6 Million
33,689 New
33,689 $5.52 Billion
Q3 2023

Feb 06, 2024

BUY
$138.78 - $176.51 $319,194 - $405,973
2,300 New
2,300 $366 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.46B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.